- Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology, 14: 267, 2000. [PubMed Abstract]
- Smith, RA, Cokkinides, V., Eyre, HJ and American Cancer Society: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin, 54: 41, 2004. [PubMed Abstract]
- National Comprehensive Cancer Network: Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology-version 1.2004.
- U.S. Preventive Services Task Force: Screening for Prostate Cancer: Recommendations and Rationale. Rockville, Maryland: Agency for Healthcare Research and Quality, 2002.
- Screening for prostate cancer. American College of Physicians. Ann Intern Med, 126: 480, 1997. [PubMed Abstract]
- Catalona, WJ, Smith, DS, Ratliff, TL, Dodds, KM, Coplen, DE, Yuan, JJ et al: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med, 324: 1156, 1991. [PubMed Abstract]
- Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schonitzer D, Severi G, Robertson C, Boyle P, Bartsch G. Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol, 12 Suppl 1: 7, 2005. [PubMed Abstract]
- Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlen BJ, Johansson JE: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med, 352: 1977, 2005. [PubMed Abstract]
- Krumholtz, J. S., Carvalhal, GF, Ramos, CG, Smith, DS, Thorson, P., Yan, Y. et al: Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. Urology, 60: 469, 2002. [PubMed Abstract]
- D'Amico, AV, Chen, MH, Roehl, KA and Catalona, WJ: Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med, 351: 125, 2004. [PubMed Abstract]
|
